About MedGenome
MedGenome is a company based in Bengaluru (India) founded in 2013 by Mahesh Pratapneni.. MedGenome has raised $264.5 million across 10 funding rounds from investors including HDFC, HDFC Mutual Fund and International Finance Corporation. The company has 883 employees as of April 05, 2024. MedGenome has completed 3 acquisitions, including Lifecode, Prognosis and Trident Diagnostics. MedGenome offers products and services including Sequencing Services and Bioinformatics Services. MedGenome operates in a competitive market with competitors including Foundation Medicine, Personalis, Novogene Corporation, Lantern Pharma and Burning Rock, among others.
- Headquarter Bengaluru, India
- Employees 883 as on 05 Apr, 2024
- Founders Mahesh Pratapneni
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Medgenome Labs Limited
- Date of Incorporation 08 Apr, 2013
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$29.55 M (USD)9.65as on Mar 31, 2023
-
Net Profit
$-1.72 M (USD)-141.12as on Mar 31, 2023
-
EBITDA
$-1.58 M (USD)-128.46as on Mar 31, 2023
-
Total Equity Funding
$264.5 M (USD)
in 10 rounds
-
Latest Funding Round
$47.5 M (USD), Series E
Jul 21, 2025
-
Investors
HDFC
& 24 more
-
Employee Count
883
as on Apr 05, 2024
-
Investments & Acquisitions
Lifecode
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedGenome
MedGenome offers a comprehensive portfolio of products and services, including Sequencing Services and Bioinformatics Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers DNA, RNA, and single-cell sequencing for research applications.
Provides analysis of genomic data for insights and publications.
Unlock access to complete
Unlock access to complete
Funding Insights of MedGenome
MedGenome has successfully raised a total of $264.5M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $47.5 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series E — $47.5M
-
First Round
First Round
(20 Aug 2013)
- Investors Count 25
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Series E - MedGenome | Valuation | Maj Invest | |
| Aug, 2022 | Amount | Series D - MedGenome | Valuation | Novo Holdings | |
| Jul, 2021 | Amount | Series D - MedGenome | Valuation | Kemwel |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MedGenome
MedGenome has secured backing from 25 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include HDFC, HDFC Mutual Fund and International Finance Corporation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by Sofina to emerging companies.
|
Founded Year | Domain | Location | |
|
IFC is focused on private sector development in emerging markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MedGenome
MedGenome has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Lifecode, Prognosis and Trident Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of radiology, pathology, and other services
|
2016 | ||||
|
Molecular tumor profiling panels for solid tumors are developed.
|
2012 | ||||
|
Diagnostic services in cardiology, radiology, pathology, and imaging are offered.
|
2002 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MedGenome
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medgenome Comparisons
Competitors of MedGenome
MedGenome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, Personalis, Novogene Corporation, Lantern Pharma and Burning Rock, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| domain | founded_year | HQ Location |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medgenome
Frequently Asked Questions about MedGenome
When was MedGenome founded?
MedGenome was founded in 2013.
Where is MedGenome located?
MedGenome is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of MedGenome?
Mahesh Pratapneni is the current CEO of MedGenome. They have also founded this company.
Is MedGenome a funded company?
MedGenome is a funded company, having raised a total of $264.5M across 10 funding rounds to date. The company's 1st funding round was a Series D of $16.5M, raised on Aug 20, 2013.
How many employees does MedGenome have?
As of Apr 05, 2024, the latest employee count at MedGenome is 883.
What is the annual revenue of MedGenome?
Annual revenue of MedGenome is $29.55M as on Mar 31, 2023.
What does MedGenome do?
MedGenome was founded in 2013 and is headquartered in Bengaluru, India, within the genomics and biotechnology sector. A range of services is offered, including whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. Bioinformatics assistance, such as analysis pipelines and data visualization tools, is provided to support research efforts in rare diseases, cancer, and antibody discovery.
Who are the top competitors of MedGenome?
MedGenome's top competitors include Foundation Medicine, Personalis and Novogene Corporation.
What products or services does MedGenome offer?
MedGenome offers Sequencing Services and Bioinformatics Services.
How many acquisitions has MedGenome made?
MedGenome has made 3 acquisitions, including Lifecode, Prognosis, and Trident Diagnostics.
Who are MedGenome's investors?
MedGenome has 25 investors. Key investors include HDFC, HDFC Mutual Fund, International Finance Corporation, LeapFrog, and HDFC Life.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.